Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / AUPH - Aurinia Pharma's voclosporin nabs accelerated review for kidney inflammation


AUPH - Aurinia Pharma's voclosporin nabs accelerated review for kidney inflammation

  • The FDA has accepted Aurinia Pharmaceuticals' (NASDAQ:AUPH) New Drug Application (NDA) for voclosporin, as a potential treatment for lupus nephritis, an inflammation of the kidneys caused by the autoimmune disease systemic lupus erythematosus.
  • More news on: Aurinia Pharmaceuticals Inc., Healthcare stocks news,
  • Read more ...
Stock Information

Company Name: Aurinia Pharmaceuticals Inc
Stock Symbol: AUPH
Market: NASDAQ
Website: auriniapharma.com

Menu

AUPH AUPH Quote AUPH Short AUPH News AUPH Articles AUPH Message Board
Get AUPH Alerts

News, Short Squeeze, Breakout and More Instantly...